Snapshot

Investor Snapshot

Company

BARD1 Life Sciences Ltd

Description

BARD1 Life Sciences Ltd is an Australian life sciences company developing novel diagnostics and therapeutics for unmet needs in cancer

Headquarters

Perth, Australia

Employees

Less than 10

ASX Code

BD1 (listed 20 June 2016)

Sector

Healthcare

Shares on issue

742 million

Market Capitalisation

A$5.94 million (at A$0.008/share)

52 Week H/L

A$0.064 – 0.007

Board of Directors

Peter Gunzburg                           Chairman

Dr Irmgard Irminger-Finger    Executive Director

Prof Geoff Laurent                     Non-Executive Director

Brett Montgomery                      Non-Executive Director

Key Management

Dr Leearne Hinch                       Chief Executive Officer

Dr Irmgard Irminger-Finger    Chief Scientific Officer

Company Secretary

Pauline Collinson

Products

BARD1 Lung Cancer Test is a non-invasive blood test in development for early detection of lung cancer

BARD1 Ovarian Cancer Test is a non-invasive blood test in development for early detection of ovarian cancer